BDBM275851 5-chloro-N-(N,N- dimethylsulfamoyl)-2- fluoro-4-(2-fluoro- 5-(trifluoromethoxy) phenoxy)benzamide::US10071957, Example 70
SMILES: CN(C)S(=O)(=O)NC(=O)c1cc(Cl)c(Oc2cc(OC(F)(F)F)ccc2F)cc1F
InChI Key: InChIKey=DMOWZHLXAOOOBV-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium channel protein type 9 subunit alpha (Homo sapiens (Human)) | BDBM275851 (5-chloro-N-(N,N- dimethylsulfamoyl)-2- fluoro-4-(2...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 340 | n/a | n/a | n/a | n/a | 7.4 | 25 |
GENENTECH, INC.; XENON PHARMACEUTICALS INC. US Patent | Assay Description Preparation of membranes containing recombinantly expressed sodium channels: Frozen recombinant cell pellets were thawed on ice and diluted to 4 time... | US Patent US10071957 (2018) BindingDB Entry DOI: 10.7270/Q2J1056P | |||||||||||
More data for this Ligand-Target Pair |